查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842092

美国肿瘤资讯系统市场规模、份额和趋势分析报告：按产品和服务、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. Oncology Information Systems Market Size, Share & Trends Analysis Report By Product & Service, By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年美国肿瘤资讯系统市值将达到 9.029 亿美元，2025 年至 2033 年的复合年增长率将达到 7.56%。

美国市场的发展受到各年龄层癌症发生率上升以及对先进创新型肿瘤资讯系统 (OIS) 需求成长的推动。由于癌症发病率上升和医疗保健预算增加，美国医院和癌症研究所越来越多地采用癌症资讯解决方案。

由于癌症发病率上升以及先进医疗IT解决方案的日益整合，美国肿瘤资讯系统 (OIS) 市场预计将经历显着增长。根据美国国家癌症美国的数据，到2024年，美国将新增超过200万例癌症病例，并有611,720例癌症相关死亡病例。不断上升的发病率需要强大的数据管理和临床决策支援系统，从而加速了医疗机构对OIS平台的需求。

此外，美国医疗保健产业正在经历数位科技应用的激增，旨在优化工作流程、行政职能和患者照护。具有治疗计划、数据视觉化和患者追踪等先进功能的肿瘤资讯系统正在成为改善临床结果和营运效率的关键工具。

此外，在公共和私人机构的支持下，肿瘤学研发投入的增加正在刺激产品创新。例如，成立于1978年的着名非营利组织美国近距离放射治疗协会（ABS）积极透过专业教育、研究推广和提高意识的倡议，支持近距离放射治疗的发展。此类组织在推动癌症治疗创新和知识传播方面发挥着至关重要的作用。

人工智慧 (AI) 日益融入肿瘤学工作流程，预计将进一步推动美国肿瘤资讯系统产业的扩张。 2024 年 10 月，McKesson Corporation 的子公司 Ontada 与微软合作，利用 Azure AI（包括 Azure OpenAI 服务）增强非结构化肿瘤资料的处理能力。此次合作旨在从复杂的临床文件中提取切实可行的见解，最终支持数据驱动的治疗计划和即时决策。

癌症发病率上升、医疗 IT 应用日益普及、研发活动活性化以及人工智慧主导的创新都是预计在预测期内共同推动美国癌症资讯系统市场持续成长的因素。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国肿瘤资讯系统市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国肿瘤资讯系统市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国肿瘤资讯系统市场：产品与服务估计与趋势分析

  • 细分仪表板
  • 美国肿瘤资讯系统市场产品与服务变化分析
  • 2021-2033 年美国肿瘤资讯系统市场规模及趋势分析（依产品及服务）
  • 软体
    • 病人资讯系统
    • 治疗计划系统
  • 专业服务

第五章美国肿瘤资讯系统市场：应用估计与趋势分析

  • 细分仪表板
  • 美国肿瘤资讯系统市场使用变化分析
  • 2021-2033 年美国肿瘤资讯系统市场规模及应用趋势分析
  • 肿瘤内科
  • 放射肿瘤学
  • 外科肿瘤学

第六章美国肿瘤资讯系统市场：最终用途估计与趋势分析

  • 细分仪表板
  • 美国肿瘤资讯系统市场最终用途差异分析
  • 美国肿瘤资讯系统市场规模和趋势分析（按最终用途），2021-2033 年
  • 医院和诊断影像
  • 消融护理中心和癌症护理中心
  • 政府机构
  • 研究设施

第七章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Elekta AB
    • Accuray Incorporated
    • Varian Medical Systems（Siemens Healthineers）
    • RaySearch Laboratories
    • Oracle Corporation
    • BrainLab
    • Philips Healthcare
    • Prowess, Inc.
    • DOSIsoft SA
    • ViewRay Inc.
    • MIM Software
    • Flatiron
Product Code: GVR-4-68040-287-5

Market Size & Trends:

The U.S. oncology information systems market size was estimated at USD 900.29 million in 2024 and is projected to grow at a CAGR of 7.56% from 2025 to 2033. The growing prevalence of cancer among various demographics and the rising demand for advanced innovative oncology information systems (OIS) are some of the driving factors for the U.S. market. Oncology information solutions deployment is high in hospitals & cancer research institutes in the U.S. due to the rise in the prevalence of cancer and the increase in healthcare expenditure budget.

The U.S. oncology information system (OIS) market is poised for significant growth, driven by the rising cancer burden and the increasing integration of advanced healthcare IT solutions. According to the National Cancer Institute, over 2 million new cancer cases are projected to be diagnosed in the U.S. in 2024, with an estimated 611,720 cancer-related deaths. This escalating disease incidence necessitates robust data management and clinical decision support systems, thereby accelerating the demand for OIS platforms across healthcare facilities.

Moreover, the healthcare sector in the U.S. has witnessed a surge in the adoption of digital technologies aimed at optimizing workflows, administrative functions, and patient care delivery. Oncology information systems, equipped with advanced functionalities such as treatment planning, data visualization, and patient tracking, have emerged as critical tools for improving clinical outcomes and operational efficiency.

Furthermore, increased investment in oncology R&D, supported by both public and private organizations, is fostering product innovation. For instance, the American Brachytherapy Society (ABS), a prominent nonprofit founded in 1978, actively supports the advancement of brachytherapy through professional education, research promotion, and awareness-building initiatives. Such organizations play a pivotal role in driving innovation and knowledge dissemination in oncology care.

The growing integration of artificial intelligence (AI) into oncology workflows is expected to further propel the expansion of the U.S. oncology information systems industry. In October 2024, Ontada, a McKesson Corporation subsidiary, partnered with Microsoft to utilize Azure AI, including Azure OpenAI Service, to enhance the processing of unstructured oncology data. This collaboration aims to extract actionable insights from complex clinical documents, ultimately supporting data-driven treatment planning and real-time decision-making.

These factors, such as rising cancer prevalence, expanding healthcare IT adoption, increased R&D activities, and AI-driven innovation, are collectively expected to drive sustained growth of the U.S. oncology information system market over the forecast period.

U.S. Oncology Information Systems Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. oncology information systems market report based on product & service, application, and end use:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Professional Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Government Institutions
  • Research Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Oncology Information Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. U.S. Oncology Information Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape

Chapter 4. U.S. Oncology Information Systems Market: Product & Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Oncology Information Systems Market Product & Service Movement Analysis
  • 4.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Patient Information Systems
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Treatment Planning Systems
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Professional Services
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Oncology Information Systems Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Oncology Information Systems Market Application Movement Analysis
  • 5.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Medical Oncology
    • 5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Radiation Oncology
    • 5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Surgical Oncology
    • 5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Oncology Information Systems Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Oncology Information Systems Market End Use Movement Analysis
  • 6.3. U.S. Oncology Information Systems Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Diagnostic Imaging
    • 6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Ablation Care Centers and Cancer Care Centers
    • 6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Government Institutions
    • 6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Research Facilities
    • 6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Elekta AB
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Accuray Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Varian Medical Systems (Siemens Healthineers)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. RaySearch Laboratories
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Oracle Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. BrainLab
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Philips Healthcare
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Prowess, Inc.
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. DOSIsoft S.A.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. ViewRay Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. MIM Software
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Flatiron
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. oncology information systems market, by component, 2021 - 2033 (USD Million)
  • Table 3 U.S. oncology information systems market, by application, 2021 - 2033 (USD Million)
  • Table 4 U.S. oncology information systems market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. oncology information systems market: Market outlook
  • Fig. 5 U.S. oncology information systems market: Segment outlook
  • Fig. 6 U.S. oncology information systems market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. oncology information systems market driver impact
  • Fig. 9 U.S. oncology information systems market restraint impact
  • Fig. 10 U.S. oncology information systems market: Product & Service outlook and key takeaways
  • Fig. 11 U.S. oncology information systems market: Product & Service movement analysis
  • Fig. 12 Software market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 13 Patient information systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Treatment planning systems market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 15 Professional services market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 16 U.S. oncology information systems market: Application outlook and key takeaways
  • Fig. 17 U.S. oncology information systems market: Application movement analysis
  • Fig. 18 Medical oncology market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 19 Medical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Surgical oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. oncology information systems market: End use outlook and key takeaways
  • Fig. 22 U.S. oncology information systems market: End use movement analysis
  • Fig. 23 Hospitals & diagnostic imaging centers market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 24 Ablation care centers and cancer care centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Government institutions market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Research facilities market estimates and forecasts, 2021 - 2033 (USD Million)